Alyssa Billingsley, PharmD

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

In part 2, Alyssa Billingsley, PharmD, explores some of the recent switches that made waves in the US and how they impact pharmacy operations as well as patient outcomes.

Alyssa Billingsley, PharmD, discusses the FDA’s prescription to over-the-counter drug development process and what it means for patients and pharmacies.